超基因医药 RARE
$15.43 −$0.14 (-0.90%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.43 0.00%
开盘$15.68
昨收$15.57
当日区间$15.12 – $15.97
成交量4.05M
市值$1.57B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数20
平均目标价$28.42+84.2% 较现价
- 买入 50%
- 持有 50%
最低 $16.00现价 $15.43均值 $28.42最高 $49.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$16.00至$39.00，平均为$24.47。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 21 Oct 2026 | Piper Sandler | BUY | $36.00 |
| 15 Oct 2026 | UBS | HOLD | $16.00 |
| 15 Oct 2026 | H.C. Wainwright | BUY | $25.00 |
| 14 Oct 2026 | UBS | HOLD | $16.00 |
| 14 Oct 2026 | H.C. Wainwright | BUY | $25.00 |
| 9 Oct 2026 | BofA Securities | HOLD | $20.00 |
| 8 Oct 2026 | H.C. Wainwright | BUY | $25.00 |
| 8 Oct 2026 | RBC Capital | HOLD | $19.00 |
| 25 Sep 2026 | H.C. Wainwright | BUY | $25.00 |
| 21 Sep 2026 | Morgan Stanley | HOLD | $20.00 |
| 21 Sep 2026 | Evercore | HOLD | $18.00 |
| 18 Sep 2026 | CCORF | BUY | $39.00 |
| 18 Sep 2026 | Wells Fargo | HOLD | $18.00 |
| 18 Sep 2026 | William Blair | HOLD | – |
| 18 Sep 2026 | BofA Securities | HOLD | $20.00 |
| 18 Sep 2026 | Wedbush | HOLD | $23.00 |
| 18 Sep 2026 | Morgan Stanley | HOLD | $20.00 |
| 18 Sep 2026 | Citi | BUY | $32.00 |
| 18 Sep 2026 | Leerink Partners | BUY | $33.00 |
| 18 Sep 2026 | Barclays | BUY | $35.00 |
暂无评论——快来第一个聊聊 RARE。
登录后参与讨论。